✦ LIBER ✦

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm

✍ Scribed by Beer, P. A.; Delhommeau, F.; LeCouedic, J. P.; Dawson, M. A.; Chen, E.; Bareford, D.; Kusec, R.; McMullin, M. F.; Harrison, C. N.; Vannucchi, A. M.

Book ID: 111655858
Publisher: American Society of Hematology
Year: 2010
Tongue: English
Weight: 987 KB
Volume: 115
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2009-08-236596

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A germline JAK2 SNP is associated with p

A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms

✍ Kilpivaara, Outi; Mukherjee, Semanti; Schram, Alison M; Wadleigh, Martha; Mullal 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 477 KB

Chromosomal abnormalities in transformed

Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations

✍ Florence Nguyen-Khac; Claude Lesty; Virginie Eclache; Lucile Couronné; Olivier K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

## Abstract Evolution to myelofibrosis (MF), acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) may occur over time in myeloproliferative neoplasms (MPN) patients most likely due to the acquisition of additional mutations. The Groupe Francophone de cytogenetique hematologique (GFCH) has c